AI has the potential to revolutionize healthcare worldwide. In drug discovery, AI has already shown success. Sumitomo Dainippon Pharma and the UK-based AI company Exscientia developed DSP-1181 to treat obsessive compulsive...more
3/11/2021
/ Algorithms ,
Artificial Intelligence ,
Biotechnology ,
Coronavirus/COVID-19 ,
Food and Drug Administration (FDA) ,
Infectious Diseases ,
Life Sciences ,
Machine Learning ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Research and Development
On August 26, 2020, the U.S. Food and Drug Administration approved Foundation Medicine, Inc.’s Foundation One® Liquid CDx, a quantitative next-generation sequencing (NGS) test that can detect mutations using circulating...more